FDA advisers recommend strain update to Covid-19 boosters ahead of expected fall surge
The advisory committee signaled a preference for the strain composition to target the BA.4 and BA.5 subvariants.
The advisory committee signaled a preference for the strain composition to target the BA.4 and BA.5 subvariants.
The FDA is expected to quickly authorize the vaccines for emergency use.
The FDA analyzed the vaccines’ ability to induce neutralizing antibody responses in kids that were comparable to young adults, a concept known as immunobridging. Both met the agency’s success criteria.
Panel members largely agreed that the benefits of having another vaccine available to these age groups outweigh the potential risks.
The FDA analyzed the vaccines’ ability to induce neutralizing antibody responses in kids that were comparable to young adults, a concept known as immunobridging. Both met the agency’s success criteria.
One program covers nearly three times as many vaccines today as it did when it was created three decades ago. Despite bipartisan calls for change, Congress has failed to act.
One program covers nearly three times as many vaccines today as it did when it was created three decades ago. Despite bipartisan calls for change, Congress has failed to act.
One program covers nearly three times as many vaccines today as it did when it was created three decades ago. Despite bipartisan calls for change, Congress has failed to act.
One program covers nearly three times as many vaccines today as it did when it was created three decades ago. Despite bipartisan calls for change, Congress has failed to act.
One program covers nearly three times as many vaccines today as it did when it was created three decades ago. Despite bipartisan calls for change, Congress has failed to act.
One program covers nearly three times as many vaccines today as it did when it was created three decades ago. Despite bipartisan calls for change, Congress has failed to act.
The push to develop daily oral contraceptives without prescription has been years in the making.
The push to develop daily oral contraceptives without prescription has been years in the making.
The push to develop daily oral contraceptives without prescription has been years in the making.
The surge of Covid-19 infections in Washington this week has many wondering if it’s safe enough to hold indoor, public events again.
The surge of Covid-19 infections in Washington this week has many wondering if it’s safe enough to hold indoor, public events again.
Panel members agreed that myriad unknowns persist about the coronavirus and how it might evolve.
The surge of Covid-19 infections in Washington this week has many wondering if it’s safe enough to hold indoor, public events again.
Panel members agreed that myriad unknowns persist about the coronavirus and how it might evolve.
Panel members agreed that myriad unknowns persist about the coronavirus and how it might evolve.
The request for a second booster shot is based on two real-world data sets suggesting another vaccine dose boosts protection against the Omicron variant while maintaining its safety profile.
The request for a second booster shot is based on two real-world data sets suggesting another vaccine dose boosts protection against the Omicron variant while maintaining its safety profile.
Licensure doesn’t materially affect the status quo — the licensed vaccine’s formula is identical to that authorized for emergency use.
Licensure doesn’t materially affect the status quo — the licensed vaccine’s formula is identical to that authorized for emergency use.
Licensure doesn’t materially affect the status quo — the licensed vaccine’s formula is identical to that authorized for emergency use.
Licensure doesn’t materially affect the status quo — the licensed vaccine’s formula is identical to that authorized for emergency use.
The FDA said it would convene its independent panel of vaccine experts Feb. 15 to consider the data.
The FDA said it would convene its independent panel of vaccine experts Feb. 15 to consider the data.
A flurry of regulatory, testing and logistical issues is complicating the rollout.
A flurry of regulatory, testing and logistical issues is complicating the rollout.